Pursuant to Regulation 32 of SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, Chemkart India Limited hereby submits Statement on deviation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemkart India has confirmed to BSE that there are no deviations or variations in the use of proceeds from its Initial Public Offer for the half-year ended September 30, 2025. The company raised Rs. 64.48 crore through the IPO in July 2025 and is monitored by Brickworks Rating Limited. Out of the total, Rs. 20 crore allocated for repayment of borrowings has been fully utilized, while Rs. 9.80 crore for general corporate purposes and IPO expenses has also been used in full. Only Rs. 0.50 crore has been deployed so far out of Rs. 34.68 crore earmarked for setting up a manufacturing facility through its wholly-owned subsidiary Easy Raw Materials Pvt Ltd, with the rest likely to be spent in coming quarters. The Audit Committee and Board reviewed and took the statement on record on November 10, 2025.
This is a routine compliance filing that should reassure shareholders that IPO money is being used as promised. The slow utilization of manufacturing capex (just 1.4% deployed) is worth tracking but not a red flag yet, as such projects typically spend over multiple quarters.